Enfermedades inflamatorias y neoplásicas del tracto gastrointestinal, enfermedades hepáticas prevalentes
ENGASTRO
Hospital Costa Del Sol
Marbella, EspañaPublicaciones en colaboración con investigadores/as de Hospital Costa Del Sol (6)
2019
-
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672
2018
-
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Gastroenterologia y Hepatologia, Vol. 41, Núm. 5, pp. 328-349
-
Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349] (S0210570518300037) (10.1016/j.gastrohep.2017.12.003))
Gastroenterologia y Hepatologia
2016
-
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Journal of Hepatology, Vol. 65, Núm. 3, pp. 532-542
2011
-
The changing face of hospitalisation due to gastrointestinal bleeding and perforation
Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 585-591
2005
-
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use
American Journal of Gastroenterology, Vol. 100, Núm. 8, pp. 1685-1693